D144DRG Entrust Escudo
Implantable Cardioverter Defibrillator (ICD)
D144DRG Entrust Escudo
Information

Device Survival Probability

D144DRG_D154ATG_D154DRG_SURV
Loading...










    1 yr 2 yr 3 yr 4 yr 5 yr 6 yr 7 yr 8 yr at 102.0 mo                        
% Excluding Normal Battery Depletion 100.0 99.9 99.8 99.6 99.4 99.4 99.3 99.3 99.3                        
% Including Normal Battery Depletion 99.3 99.0 98.4 96.9 89.6 69.4 36.0 7.2 1.2                        
#   24828 22610 20237 17789 14668 10501 4936 856 132                        
  • Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
  • Excluding Normal Battery Depletion – This is the malfunction free survival curve.

Performance Notes For This Model

    • There are no performance notes for this model.
Information

Product Characteristics

Generator Type ICD
NBD Code VVE-DDDR
Max. Delivered Energy 35 J
More
Connector Style DR Style
Serial Number Prefix PNR
Mass 68 g
Volume 35 cc
Waveform Biphasic
X-Ray ID PNR
Hide this content
DR Style
Information

Estimated Longevity

Charging Frequency 100% Pacing 50% Pacing 15% Pacing 100% Sensing
Monthly 3.8 4.2 4.4 4.6
Quarterly 5.5 6.1 6.8 7.0
Semi-annual 6.1 7.0 7.9 8.3
Footnote

Longevity estimates based on the following device usage. Pacing Mode DDD; Atrial Lower Pacing Rate 60ppm; Ventricular Lower Pacing Rate 60ppm; Atrial Pulse Width 0.4ms; Ventricular Pulse Width 0.4ms; Atrial Pulse Amplitude 3V; Ventricular Pulse Amplitude 3V; Atrial Impedance 510ohms; Ventricle Impedance 510ohms; Atrial Sensing Rate 70bpm; Ventricle Sensing Rate 70bpm; EGM prestorage OFF; Optivol ON; Atrial Fib percentage of time 0%; Charging frequency assumes maximum energy charge and includes therapy shocks and capacitor formation. Hide this content

Information

Distribution Data

US Market Release
CE Approval Date2008-06-05
Registered USA Implants
Estimated Active USA Implants
Normal Battery Depletions
US Market Release
CE Approval Date2008-06-05
Estimated WW Distribution1860
Normal Battery Depletions9
Information

Malfunctions (USA)

Therapy Function Not Compromised
Therapy Function Compromised
Information

Malfunctions (WW)

Therapy Function Not Compromised 2
Possible Early Battery Depletion 1
Software/Firmware 1
Therapy Function Compromised 1
Battery 1
Information

EOL Indication

EOL device status is defined as three months following an ERI indication assuming the following post-ERI conditions: 100% DDD pacing at 60 min-1, 2.5 V, 0.4 ms; 500 Ohm pacing load; and six full-energy charges. EOL may be indicated before the end of three months if the device exceeds these conditions.

Information

Elective Replacement (ERI)

Battery voltage less than or equal to 2.61 V on three consecutive daily automatic measurements.

Information

Charge Time

D144DRG_D154ATG_D154DRG_CHRG
Loading...

Data as of October 12, 2018

www.medtronic.com/productperformance 626050